Pioglitazone for diabetes prevention.


n engl j med 365;2 nejm.org july 14, 2011 182 study with greater statistical power will be required to confirm these results. We agree with the criticism of Alfonso et al. with respect to the surveillance strategy that was used in our study. In accordance with previous practice guidelines,1 we recommended routine angiographic surveillance for patients… (More)
DOI: 10.1056/NEJMc1104572#SA1